Case Reports

Neonatal Hypermagnesemia After in Utero Exposure to Magnesium Sulfate: Case Report

Main Article Content

Mariana Gaspar
Filipa Sutre
Alexandra Gavino
Susana Moleiro
Aldina Lopes
Infant, Newborn, Diseases, Magnesium / blood, Magnesium Sulfate / adverse effects, Pre-Eclampsia / drug therapy


Magnesium sulfate (MgSO4) is currently the treatment of choice for severe preeclampsia and eclampsia. However, the risk and potential effects of neonatal hypermagnesemia are not well- recognized. The authors report the case of a late preterm male neonate whose mother was treated with MgSO4 for severe preeclampsia. Maternal hypermagnesemia, hypertension, and neurological worsening motivated emergency cesarean section. At his first minute of life, the newborn was bradycardic, cyanotic, hypotonic, and did not start to breathe spontaneously. Neonatal resuscitation was performed, requiring endotracheal intubation and immediate admission to the Neonatal Unit for mechanical ventilation and continuous cardiorespiratory monitoring. The immeasurable plasmatic magnesium level was compatible with the diagnosis of hypermagnesemia. Symptoms and signs slowly disappeared as magnesium values normalized and respiratory function was fully recovered hours later. This case shows a rare but reversible cause of neonatal respiratory depression and hypotonia in the context of maternal MgSO4 infusion.

Article Details

How to Cite
Case Reports


Costantine MM, Weiner SJ; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal–Fetal Medicine Units Network (MFMU). Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol. 2009;114:354-64. doi: 10.1097/AOG.0b013e3181ae98c2.

Girsen AI, Greenberg MB, El-Sayed YY, Lee H, Carvalho B, Lyell DJ. Magnesium sulfate exposure and neonatal intensive care unit admission at term. J Perinatol. 2015;35:181-5. doi: 10.1038/jp.2014.184.

Menéndez-Hernando C, Huerga-López A, Martín-Molina R, Fariñas-Salto M, Chacón-Aguilar R. . Hipermagnesemia neonatal secundaria a intoxicación por laxante oral con sales de magnesio. Rev Mex Pediatria. 2019;86:194-6.

Stone JH. HELLP syndrome: hemolysis, elevated liver enzymes, and low platelets. JAMA. 1998;280:559-62. doi: 10.1001/jama.280.6.559.

Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res. 2019;124:1094-112. doi: 10.1161/CIRCRESAHA.118.313276. Erratum in: Circ Res. 2020;126:e8.

Altman D, Carroli G, Duley L, Farrell B, Moodley J, et al; Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877-90. doi: 10.1016/s0140-6736(02)08778-0.

Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 2008;359:895-905. doi: 10.1056/NEJMoa0801187.

Crowther CA, Hiller JE, Doyle LW, Haslam RR; Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA. 2003;290:2669-76. doi: 10.1001/jama.290.20.2669.

Rasch DK, Huber PA, Richardson CJ, L'Hommedieu CS, Nelson TE, Reddi R. Neurobehavioral effects of neonatal hypermagnesemia. J Pediatr. 1982;100:272-6. doi: 10.1016/s0022-3476(82)80654-9.

Omori-Shimano S, Tominaga T, Ikeda K. Maternal magnesium sulfate administration increases early-onset hyperkalemia risk in premature infants: A propensity score-matched, case-control study. Pediatr Neonatol. 202364:119-25. doi: 10.1016/j.pedneo.2022.06.011.

Brazy JE, Grimm JK, Little VA. Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy. J Pediatr. 1982;100:265-71. doi: 10.1016/s0022-3476(82)80653-7.

Brookfield K, Su F, Drover D, Adelus M, Lyell D, Carvalho B. 823: Umbilical cord magnesium levels and neonatal resuscitation in infants exposed to magnesium sulfate. Am J Obstet Gynecol.2015;212:S395-6. 10.1016/j.ajog.2014.10.1029.

Riaz M, Porat R, Brodsky NL, Hurt H. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study. J Perinatol. 1998;18:449-54.

Abbassi-Ghanavati M, Alexander JM, McIntire DD, Savani RC, Leveno KJ. Neonatal effects of magnesium sulfate given to the mother. Am J Perinatol. 2012;29:795-9. doi: 10.1055/s-0032-1316440.

Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol. 2004;190:1520-6. doi: 10.1016/j.ajog.2003.12.057.

Ramsey PS, Rouse DJ. Magnesium sulfate as a tocolytic agent. Semin Perinatol. 2001;25:236-47. doi: 10.1053/sper.2001.27546.

Cruz OM, Doren VA, Fernández BR, Salinas TJ, Urzúa BS, Tapia IJ. Intoxicación Neonatal por Sulfato de Magnesio: Caso clínico. Rev Chil Pediatr. 2009;80:261-6. doi: 10.4067/S0370-41062009000300008.

Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114:1326-31. doi: 10.1097/AOG.0b013e3181c2bde8. Erratum in: Obstet Gynecol. 2010;115:387.

Bucklin AB. Chapter 61 – High-Risk Obstetrics. In: Keech BM, Laterza RD, editors. Anesthesia Secrets. 4th ed. Amsterdam: Elsevier; 2011. p. 426-31.